Navigation Links
Amylin Pharmaceuticals to Present at Bank of America Healthcare Conference
Date:5/7/2008

SAN DIEGO, May 7 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the Bank of America Healthcare Conference on Tuesday, May 13, 2008 at 10:00 a.m. PT in Las Vegas. Michael York, Senior Director of Investor Relations of Amylin Pharmaceuticals, will be providing a corporate overview.

The live presentation and breakout session will be webcast, and a recording will be made available following the event. The webcast and recording will be accessible through Amylin's corporate website, located at http://www.amylin.com. To access the live webcast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California with over 1,900 employees nationwide. Further information on Amylin Pharmaceuticals is available at http://www.amylin.com.


'/>"/>
SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
2. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
3. Amylin Pharmaceuticals to Webcast First Quarter Results
4. Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
5. Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program
6. Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
7. Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors
8. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
9. Amylin Pharmaceuticals Reports Third Quarter Financial Results
10. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
11. Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... Germany , October 17, 2014 /PRNewswire/ ... research in cancer and other diseases will benefit ... Society of Human Genetics annual meeting   ... Ingenuity ®  Knowledge Base greatly exceeds any comparable ... Ingenuity ®  Variant Analysis™ adds fully integrated BIOBASE ...
(Date:10/17/2014)... The Europe Fuel Additives Market report ... with analysis and forecast of revenue. , Browse through ... to get an idea of the in-depth analysis provided. ... the European fuel additives market, and is supported by ... , Fuel additives are chemicals that are used to ...
(Date:10/17/2014)... The report “Feed Antioxidants Market by Type (BHA, ... Aquatic Animals & Others), by Geography - Global Trends ... feed antioxidant market with analyses and projection of the ... feed antioxidants. , The global market for feed antioxidants, ... around $191.1 million in 2013 and is projected to ...
(Date:10/17/2014)... The report "Thermocouples and High End ... Petrochemical, Consumer Utility, Glass, and Aerospace & Defense) ... Analysis & Forecast to 2010 - 2020", defines ... pyrometer market into various sub-segments with an in-depth ... the drivers and restraints for this market with ...
Breaking Biology Technology:QIAGEN Demonstrates Expanded Bioinformatics Workflows at ASHG; Strong Market Adoption as Researchers Analyze Genomic Data on More Than a Quarter-Million Samples in Secure Private Cloud 2QIAGEN Demonstrates Expanded Bioinformatics Workflows at ASHG; Strong Market Adoption as Researchers Analyze Genomic Data on More Than a Quarter-Million Samples in Secure Private Cloud 3QIAGEN Demonstrates Expanded Bioinformatics Workflows at ASHG; Strong Market Adoption as Researchers Analyze Genomic Data on More Than a Quarter-Million Samples in Secure Private Cloud 4QIAGEN Demonstrates Expanded Bioinformatics Workflows at ASHG; Strong Market Adoption as Researchers Analyze Genomic Data on More Than a Quarter-Million Samples in Secure Private Cloud 5QIAGEN Demonstrates Expanded Bioinformatics Workflows at ASHG; Strong Market Adoption as Researchers Analyze Genomic Data on More Than a Quarter-Million Samples in Secure Private Cloud 6The Europe Fuel Additives Market is estimated to grow to $1,401.4 million by 2018 - New Report by MicroMarket Monitor 2The Europe Fuel Additives Market is estimated to grow to $1,401.4 million by 2018 - New Report by MicroMarket Monitor 3The Europe Fuel Additives Market is estimated to grow to $1,401.4 million by 2018 - New Report by MicroMarket Monitor 4Feed Antioxidants Market Projected To Reach $238.5 Million by 2018 - New Report by MarketsandMarkets 2Feed Antioxidants Market Projected To Reach $238.5 Million by 2018 - New Report by MarketsandMarkets 3Feed Antioxidants Market Projected To Reach $238.5 Million by 2018 - New Report by MarketsandMarkets 4Thermocouples Market Growing at CAGR of 3.70% & High End Optical Pyrometers Market Growing at CAGR of 13.81% - New Report 2Thermocouples Market Growing at CAGR of 3.70% & High End Optical Pyrometers Market Growing at CAGR of 13.81% - New Report 3Thermocouples Market Growing at CAGR of 3.70% & High End Optical Pyrometers Market Growing at CAGR of 13.81% - New Report 4
... the Project on Emerging Nanotechnologies (PEN) at the ... variety of voluntary options available for the oversight ... Voluntary Initiatives, Regulation, and Nanotechnology Oversight: Charting a ... Center for Environmental Policy at American University, provides ...
... content="bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics. Co-development of ... launch in 2012,bioMerieux gains exclusive rights in microbiology,bioMerieux takes equity stake ... in Molecular... -- MARCY L,ETOILE, France and LAUSANNE, Switzerland, Nov. 4, ... ...
... Novavax, Inc. (Nasdaq: NVAX ) announced ... grants under the Internal Revenue Service,s Qualifying Therapeutic Discovery ... Protection and Affordable Care Act of 2010 to provide ... of eligible qualified investments in therapeutic discovery projects during ...
Cached Biology Technology:bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics 2bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics 3bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics 4bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics 5bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics 6bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics 7bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics 8bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics 9
(Date:10/14/2014)... JOLLA, CA – October 14, 2014 – Scientists from ... million from the National Institutes of Health (NIH) to ... prevalent virus-induced hemorrhagic fever disease in Africa. The study ... and why some patients die, while others survive the ... to understand the basic mechanism of how Lassa fever ...
(Date:10/14/2014)... an international team of researchers, led by the Chinese ... journal Nature Genetics a brief genomic history ... of the tomato plant. , The C.M. Rick Tomato ... role in this study by providing seed of both ... study, which builds on the first tomato genome sequence ...
(Date:10/14/2014)... – Over the past decades, we have seen numerous ... the needs of infants for social contact and stimulation ... thrive. , Infancy and childhood are critical ... A generation of research suggests that enriched environments, full ... cognitive function. In contrast, deprivation and stress may compromise ...
Breaking Biology News(10 mins):Scripps Research Institute team receives $6.6 million to investigate deadly Lassa virus 2Institutional rearing may increase risk attention-deficit disorder 2
... the Keck School of Medicine of the University of ... estrogen, the female sex hormone, activates genes in breast-cancer ... to eventually lead to new treatments for the disease. ... of the Keck School,s Department of Biochemistry and Molecular ...
... and PARIS Nov. 15, 2011   ... authentication and endpoint protection solutions, today announced at ... France, that the company has open sourced its ... Open Source Edition (OSE), is free, portable software ...
... A $7.5 million award will help researchers harness ... create new types of antidotes for exposure to pesticides ... Institutes of Health (NIH), extends a previous grant and ... University, where chemists will collaborate with the U.S. Army ...
Cached Biology News:USC researchers discover key aspect of process that activates breast cancer genes 2DigitalPersona Open Sources New FingerJetFX Biometrics Technology for Mobile Devices, PCs and Servers 2DigitalPersona Open Sources New FingerJetFX Biometrics Technology for Mobile Devices, PCs and Servers 3Researchers get $7.5M grant to combat nerve agents 2Researchers get $7.5M grant to combat nerve agents 3
...
... Detection Kit is intended for quantitative detection ... peptides, which can result from the gradual, ... aspartic acid residues during storage or handling. ... the monitoring of charge differences for detection, ...
...
...
Biology Products: